Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid

NCT03746275 · clinicaltrials.gov ↗

COMPLETED

Status

5798

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: Rivaroxaban (BAY59-7939, Xarelto)
DRUG: Acetylsalicylic acid

Sponsor

Bayer

Collaborators

[object Object]